Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients

NCT00284934 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Diseases

Interventions

DRUG: Enteric-coated mycophenolate sodium (EC-MPS)
DRUG: Tacrolimus
DRUG: Corticosteroids

Sponsor

Novartis